Schubert & Co
- SEC CIK
- 0001894830
- Latest filing
- Jul 30, 2026
NBIX holding history
Neurocrine Biosciences Inc in every 13F filed by Schubert & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NBIX overviewAll 13F holders of NBIXFull Q2 2026 holdings
- Shares (Q2 2023)
- 0
- Sold out in Q2 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2023 | 0 | $0 | 0.0% | −8−100.0% | Sold out | Holders |
| Q1 2023 | 8 | $810 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 8 | $956 | <0.1% | +1+14.3% | Added | Holders |
| Q3 2022 | 7 | $1.00K | <0.1% | +2+40.0% | Added | Holders |
| Q2 2022 | 5 | $0 | 0.0% | −1−16.7% | Reduced | Holders |
| Q1 2022 | 6 | $1.00K | <0.1% | +2+50.0% | Added | Holders |
| Q4 2021 | 4 | $0 | 0.0% | – | No prior filing | Holders |